-
2
-
-
2442601512
-
Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of preeclampsia and eclampsia
-
Villar J, Say L, Shennan A, et al. Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of preeclampsia and eclampsia. Int J Gynecol Obstet. 2004;85(suppl 1): S28-S41.
-
(2004)
Int J Gynecol Obstet
, vol.85
, Issue.SUPPL. 1
-
-
Villar, J.1
Say, L.2
Shennan, A.3
-
3
-
-
37449022729
-
Maternal infection and risk of preeclampsia: Systematic review and metaanalysis
-
Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2008;198:7-22.
-
(2008)
Am J Obstet Gynecol
, vol.198
, pp. 7-22
-
-
Conde-Agudelo, A.1
Villar, J.2
Lindheimer, M.3
-
5
-
-
33645737208
-
WHO analysis of causes of maternal death: A systemic review
-
Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systemic review. Lancet. 2006;367:1066-1074.
-
(2006)
Lancet
, vol.367
, pp. 1066-1074
-
-
Khan, K.S.1
Wojdyla, D.2
Say, L.3
-
6
-
-
84864216683
-
Public health perspectives of preeclampsia in developing countries: Implications for health system strengthening
-
Osungbade KO, Ige OK. Public health perspectives of preeclampsia in developing countries: implications for health system strengthening. J Pregnancy. 2011;2011:481095.
-
(2011)
J Pregnancy
, vol.2011
, pp. 481095
-
-
Osungbade, K.O.1
Ige, O.K.2
-
8
-
-
74949106574
-
Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: Correlation with disease severity
-
Siddiqui AH, Irani RA, Blackwell SC, et al. Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity. Hypertension. 2010;55:386-393.
-
(2010)
Hypertension
, vol.55
, pp. 386-393
-
-
Siddiqui, A.H.1
Irani, R.A.2
Blackwell, S.C.3
-
9
-
-
80052622829
-
Receptor-activating autoantibodies and disease: Preeclampsia and beyond
-
Xia Y, Kellems RE. Receptor-activating autoantibodies and disease: preeclampsia and beyond. Expert Rev Clin Immunol. 2011;7:659-674.
-
(2011)
Expert Rev Clin Immunol
, vol.7
, pp. 659-674
-
-
Xia, Y.1
Kellems, R.E.2
-
10
-
-
0037304932
-
Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia
-
Wallukat G, Neichel D, Nissen E, et al. Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia. Can J Physiol Pharmacol. 2003;81:79-83.
-
(2003)
Can J Physiol Pharmacol
, vol.81
, pp. 79-83
-
-
Wallukat, G.1
Neichel, D.2
Nissen, E.3
-
11
-
-
10744227199
-
Circulating angiogenic factors and the risk of preeclampsia
-
Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672-683.
-
(2004)
N Engl J Med
, vol.350
, pp. 672-683
-
-
Levine, R.J.1
Maynard, S.E.2
Qian, C.3
-
12
-
-
79551488222
-
Circulating angiogenic and antiangiogenic factors in women with eclampsia
-
Vaisbuch E, Whitty JE, Hassan SS, et al. Circulating angiogenic and antiangiogenic factors in women with eclampsia. Am J Obstet Gynecol. 2011;204:152e1-152e9.
-
(2011)
Am J Obstet Gynecol
, vol.204
-
-
Vaisbuch, E.1
Whitty, J.E.2
Hassan, S.S.3
-
13
-
-
31844455050
-
Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis
-
Masuyama H, Suwaki N, Nakatsukasa H, et al. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis. Am J Obstet Gynecol. 2006;194: 551-556.
-
(2006)
Am J Obstet Gynecol
, vol.194
, pp. 551-556
-
-
Masuyama, H.1
Suwaki, N.2
Nakatsukasa, H.3
-
14
-
-
33745274791
-
Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia
-
Robinson CJ, Johnson DD, Chang EY, et al. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynecol. 2006;195:255-259.
-
(2006)
Am J Obstet Gynecol
, vol.195
, pp. 255-259
-
-
Robinson, C.J.1
Johnson, D.D.2
Chang, E.Y.3
-
15
-
-
33847618756
-
Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia
-
239.e1-239.e6
-
Vatten LJ, Eskild A, Nilsen TIL, et al. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am J Obstet Gynecol. 2007;196:239.e1-239.e6.
-
(2007)
Am J Obstet Gynecol
, vol.196
-
-
Vatten, L.J.1
Eskild, A.2
Nilsen, T.I.L.3
-
16
-
-
78049482011
-
Pregnancy-induced hypertension and preeclampsia: Levels of angiogenic factors in Malaysian women
-
Yelumalai S, Muniandy S, Omar SZ, et al. Pregnancy-induced hypertension and preeclampsia: levels of angiogenic factors in Malaysian women. J Clin Biochem Nutr. 2010;47:191-197.
-
(2010)
J Clin Biochem Nutr
, vol.47
, pp. 191-197
-
-
Yelumalai, S.1
Muniandy, S.2
Omar, S.Z.3
-
17
-
-
78149431733
-
Soluble fms-like tyrosine kinase 1 (sFlt-1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies
-
Powers RW, Jeyabalan A, Clifton RG, et al. Soluble fms-like tyrosine kinase 1 (sFlt-1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS One. 2010;5:e13263.
-
(2010)
PLoS One
, vol.5
-
-
Powers, R.W.1
Jeyabalan, A.2
Clifton, R.G.3
-
18
-
-
34548446787
-
Angiogenic factors for the prediction of preeclampsia in high-risk women
-
244e1-244.e8
-
Moore Simas TA, Crawford SL, Solitro MJ, et al. Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol. 2007;197:244.e1-244.e8.
-
(2007)
Am J Obstet Gynecol
, vol.197
-
-
Moore, S.T.A.1
Crawford, S.L.2
Solitro, M.J.3
-
19
-
-
0033081272
-
Obstetric and newborn outcomes in a cohort of HIV-infected pregnant women: A report of the women and infants transmission study
-
Stratton P, Tuomala RE, Abboud R, et al. Obstetric and newborn outcomes in a cohort of HIV-infected pregnant women: a report of the women and infants transmission study. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:179-186.
-
(1999)
J Acquir Immune Defic Syndr Hum Retrovirol
, vol.20
, pp. 179-186
-
-
Stratton, P.1
Tuomala, R.E.2
Abboud, R.3
-
20
-
-
0037068948
-
Preeclampsia, antiretroviral therapy, and immune reconstitution
-
Wimalasundera RC, Larbalestier N, Smith JH, et al. Preeclampsia, antiretroviral therapy, and immune reconstitution. Lancet. 2002;360: 1152-1154.
-
(2002)
Lancet
, vol.360
, pp. 1152-1154
-
-
Wimalasundera, R.C.1
Larbalestier, N.2
Smith, J.H.3
-
21
-
-
29144502449
-
Increased risk of preeclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy
-
Suy A, Martinez E, Coll O, et al. Increased risk of preeclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS. 2006;20:59-66.
-
(2006)
AIDS
, vol.20
, pp. 59-66
-
-
Suy, A.1
Martinez, E.2
Coll, O.3
-
22
-
-
73949121009
-
The safety of highly active antiretroviral therapy for HIV-positive pregnant mother and her baby: Is the more the merrier?
-
Martin F, Taylor GP. The safety of highly active antiretroviral therapy for HIV-positive pregnant mother and her baby: is "the more the merrier"? J Antimicrob Chemother. 2009;64:895-900.
-
(2009)
J Antimicrob Chemother
, vol.64
, pp. 895-900
-
-
Martin, F.1
Taylor, G.P.2
-
23
-
-
80052969116
-
Risk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in Botswana
-
Parekh N, Ribaudo H, Souda S, et al. Risk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in Botswana. Int J Gynecol Obstet. 2011;115:20-25.
-
(2011)
Int J Gynecol Obstet
, vol.115
, pp. 20-25
-
-
Parekh, N.1
Ribaudo, H.2
Souda, S.3
-
24
-
-
77953725982
-
Antiretroviral regimens in pregnancy and breast-feeding in Botswana
-
Shapiro R, Hughes M, Ogwu A, et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med. 2010;362:2282-2294.
-
(2010)
N Engl J Med
, vol.362
, pp. 2282-2294
-
-
Shapiro, R.1
Hughes, M.2
Ogwu, A.3
-
26
-
-
33748421660
-
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
-
Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:992-1005.
-
(2006)
N Engl J Med
, vol.355
, pp. 992-1005
-
-
Levine, R.J.1
Lam, C.2
Qian, C.3
-
27
-
-
7044239727
-
Soluble vascular endothelial growth factor receptor-1 (sflt-1) is increased throughout gestation in patients who have preeclampsia develop
-
McKeeman GC, Ardill JE, Caldwell CM, et al. Soluble vascular endothelial growth factor receptor-1 (sflt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol. 2004; 191:1240-1246.
-
(2004)
Am J Obstet Gynecol
, vol.191
, pp. 1240-1246
-
-
McKeeman, G.C.1
Ardill, J.E.2
Caldwell, C.M.3
-
28
-
-
69349103203
-
Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy
-
315.e1-315.e5
-
Haeri S, Shauer M, Dale M, et al. Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy. Am J Obstet Gynecol. 2009;201:315. e1-315.e5.
-
(2009)
Am J Obstet Gynecol
, vol.201
-
-
Haeri, S.1
Shauer, M.2
Dale, M.3
-
29
-
-
84866059552
-
-
9-11 November 2010. Geneva, Switzerland: World Health Organization, Available at, Accessed November 30, 2012
-
WHO. Towards the Elimination of Mother-to-Child Transmission of HIV: Report of a WHO Technical Consultation (9-11 November 2010). Geneva, Switzerland: World Health Organization; 2011. Available at: http://whqlibdoc. who.int/publications/2011/9789241501910-eng.pdf. Accessed November 30, 2012.
-
(2011)
Towards the Elimination of Mother-to-Child Transmission of HIV: Report of a WHO Technical Consultation
-
-
|